[Comment of J. Fritze: Is therapy of obesity with orlistat medically necessary?]

MeSH terms

• Anti-Obesity Agents / adverse effects
• Anti-Obesity Agents / economics
• Anti-Obesity Agents / therapeutic use*
• Cost-Benefit Analysis
• Germany
• Humans
• Lactones / adverse effects
• Lactones / economics
• Lactones / therapeutic use*
• Obesity / drug therapy*
• Obesity / economics
• Orlistat
• Treatment Outcome